ReviewCurrent gastroenterology reports2026
From Diet to Dysbiosis: The Microbiome's Relationship to Eosinophilic Esophagitis.
Review in Current gastroenterology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purpose of the reviewEosinophilic esophagitis is a chronic, type 2 inflammatory disease of the esophagus. Diet elimination trials suggest that EoE is triggered by food antigens, however, incomplete response rates present gaps in our understanding. This review aims to synthesize current evidence surrounding the diet-microbiome-immune axis in EoE and propose a conceptual framework for how dietary interventions may influence disease beyond antigen elimination. RECENT
findingsMany studies on the EoE microbiome highlight descriptive differences in cross-sectional cohorts, although findings remain inconsistent and lack a unifying disease signature. We highlight evidence from broader mucosal and gastrointestinal microbiome research and discuss the importance of microbial metabolic function and their role in regulating epithelial barrier integrity and immune responses. We present the case that in EoE, elimination diets may unintentionally alter microbial substrates and metabolic activity, leading to heterogeneity in treatment response independent of dietary antigen removal. We review early and limited experimental data that suggest microbial metabolites such as short-chain fatty acids may influence esophageal barrier function and identify gaps in understanding mechanistic and longitudinal implications for patients. The interactions and implications of the diet-microbiome-immune axis is ripe for exploration. We explore reframing elimination diets to think beyond the antigens being removed, and probe what microbially active foods may be introduced (or not) and thus have clinically relevant microbiome-modulating properties. Future work should prioritize longitudinal, diet-controlled, and multi-omic approaches to elucidate causal relationships and support the development of microbiome-informed, precision dietary strategies in EoE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.